BioCentury | Sep 29, 2016
Distillery Therapeutics
Therapeutics: Prostate cancer associated ncRNA transcript-1 (PCAT-1)
...PCAT-1 could help treat prostate cancer. In three human prostate cancer cell lines, siRNA targeting PCAT-1...
...siRNA. In a xenograft mouse model of prostate cancer, a locked nucleic acid (LNA) targeting PCAT-1...
...Next steps could include identifying and testing PCAT-1 inhibitors in models of prostate cancer. TARGET/MARKER/PATHWAY: Prostate cancer associated ncRNA transcript-1 (PCAT-1)...
...siRNA. In a xenograft mouse model of prostate cancer, a locked nucleic acid (LNA) targeting PCAT-1...
...Next steps could include identifying and testing PCAT-1 inhibitors in models of prostate cancer. TARGET/MARKER/PATHWAY: Prostate cancer associated ncRNA transcript-1 (PCAT-1)...